A Functional Homologous Recombination Assay Predicts Primary Chemotherapy Response and Long-Term Survival in Ovarian Cancer Patients

Research output: Contribution to journalArticleScientificpeer-review

Manuela Tumiati, Sakari Hietanen, Johanna Hynninen, Elina Pietilä, Anniina Färkkilä, Katja Kaipio, Pia Roering, Kaisa Huhtinen, Amjad Alkodsi, Yilin Li, Rainer Lehtonen, Erdogan Pekcan Erkan, Minna M. Tuominen, Kaisa Lehti, Sampsa K. Hautaniemi, Anna Vähärautio, Seija Grenman, Olli Carpen, Liisa Kauppi

LanguageEnglish
JournalClinical Cancer Research
Volume24
Issue number18
Pages4482-4493
Number of pages12
ISSN1078-0432
DOIs
Publication statusPublished - 15 Sep 2018
MoE publication typeA1 Journal article-refereed

    Research areas

  • DNA-REPAIR PATHWAYS, CROSS-LINK REPAIR, MUTATIONAL PROCESSES, GENOMIC INSTABILITY, SYNTHETIC LETHALITY, BREAST CANCERS, FALLOPIAN-TUBE, PHASE-2 TRIAL, DOUBLE-BLIND, PLATINUM
  • 3122 Cancers

External organisations

Hietanen, Sakari
  • Turku University Hospital
Hynninen, Johanna
  • Turku University Hospital
Färkkilä, Anniina
  • Harvard Medical School
Kaipio, Katja
  • University of Turku
  • Turku University Hospital
Roering, Pia
  • University of Turku
  • Turku University Hospital
Huhtinen, Kaisa
  • University of Turku
  • Turku University Hospital
Lehti, Kaisa
  • Karolinska Institutet
Grenman, Seija
  • Turku University Hospital
Carpen, Olli
  • University of Turku
  • Turku University Hospital

ID: 116620067